Medcompare - The Buyer's Guide for Medical Professionals Diagnostics Buyer's Guide
Products New Products News Videos Reviews Journal Updates Articles Resources Forums Events
Search Medcompare
Enter Keyword(s):


Advertisement
Adult Diapers
Articles
Genetic Analysis Systems in the Clinical Mainstream
Genetic Analysis Systems in the Clinical Mainstream
Advertisement
> > > Stratus® CS Acute Care™ Diagnostic System

Stratus® CS Acute Care™ Diagnostic System

Stratus® CS Acute Care™ Diagnostic System
General Information
VendorSiemens Healthcare Diagnostics
ItemStratus® CS Acute Care™ Diagnostic System
FeaturesStratus® CS Acute Care™ Diagnostic System - Meeting the Demand for Valuable Information The Stratus® CS Acute Care™ Diagnostic System is a model of cost effectiveness and efficiency for both your laboratory and the near-patient setting. The Stratus® CS Acute Care™ Analyzer offers the first FDA-cleared high sensitivity troponin I assay* with the low end precision to meet the 2005 ACC/AHA practice guidelines. It features a broad menu of tests that allow better chest pain differentiation from one sample, on one run, on one instrument.

Siemens Healthcare Diagnostics offers a wide variety of services, support and education:

  • Onsite training
  • A dedicated field service group
  • 24 hour technical telephone support
  • A Clinical Quality Initiatives Team
  • Audio conferences
  • Continuing education and an educational Web site

*≤10% CV at the 99th percentile for a reference population

ApprovalUS FDA
Analysis Time15 minutes to first result, and 4 minutes for each subsequent result
Quality ControlSystem check (electronic QC) reduces liquid QC frequency requirements
MarkersCK-MB, Troponin-I, Myoglobin, ßhCG, D-Dimer
PricingRequest Quote     
Related Content
Quick Pick  
Product Description

Managing Chest Pain to Meet the Challenge

More than 8 million patients with chest pain suggestive of myocardial ischemia visit Emergency Departments (EDs) annually. After initial clinical and ECG evaluation, approximately 75% of chest pain patients lack objective evidence of unstable coronary syndrome. The lack of objective evidence has generated significant challenges in the acute-care setting. Accelerated diagnostic protocols using biochemical markers and near-patient testing strategies help reduce hospital stays and resultant costs in the management of both ACS-positive and ACS-negative patients.

Go to Vendor Product Page
Go to Vendor Website
View Vendor Contact Information
NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary.